⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL4537543 | 0.98 | DPP4 (0.49) | — | |
| Hydrochloric Acid SCHEMBL30818111 | 0.81 | TAAR1 (0.47) | — | |
| Hydrochloric Acid SCHEMBL29168289 | 0.81 | TAAR1 (0.47) | — | |
| SCHEMBL4347152 | 0.79 | — | — | |
| SCHEMBL10796757 | 0.78 | HRH1 (0.49) | — | |
| SCHEMBL20897489 | 0.77 | — | — | |
| SCHEMBL30642875 | 0.77 | — | — | |
| SCHEMBL2894722 | 0.77 | — | — | |
| SCHEMBL1161332 | 0.77 | — | — | |
| SCHEMBL4455152 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-9176121-A | — | — | None | — | — | JP | disclosed |
| US-12606541-B2 | PPARg modulators and methods of use | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2026-04-21 | — | — | US | disclosed |
| US-20250368625-A1 | PIPERAZINES | Grünenthal GmbH (DE) | 2025-12-04 | — | — | US | disclosed |
| EP-4615439-A2 | SOMATOSTATIN RECEPTOR SUBTYPE 4 (SSTR4) AGONISTS AND THEIR APPLICATIONS | Humanwell Pharmaceutical US, Inc. (US) | 2025-09-17 | — | — | EP | disclosed |
| US-20250170141-A1 | MRGPRX2 MODULATORS AND RELATED METHODS OF TREATMENT | INCYTE CORPORATION | 2025-05-29 | — | — | US | disclosed |
| EP-4326717-B1 | MODIFIED FERROPORTIN INHIBITORS | VIFOR INT AG (CH) | 2025-04-16 | — | — | EP | disclosed |
| WO-2025076455-A1 | MRGPRX2 MODULATORS AND RELATED METHODS OF TREATMENT | Escient Pharmaceuticals Inc. (US) | 2025-04-10 | — | — | WO | disclosed |
| US-20240239780-A1 | MODIFIED FERROPORTIN INHIBITORS | VIFOR (INTERNATIONAL) AG (CH) | 2024-07-18 | — | — | US | disclosed |
| US-20240174693-A1 | SOMATOSTATIN RECEPTOR SUBTYPE 4 (SSTR4) AGONISTS AND THEIR APPLICATIONS | YICHANG HUMANWELL PHARMACEUTICALS CO., LTD. (CN) | 2024-05-30 | — | — | US | disclosed |
| WO-2024102754-A2 | SOMATOSTATIN RECEPTOR SUBTYPE 4 (SSTR4) AGONISTS AND THEIR APPLICATIONS | HUMANWELL PHARMACUETICAL US, INC. (US) | 2024-05-16 | — | — | WO | disclosed |
| CN-101370765-A | Method for selectively producing primary amine | SUMITOMO CHEMICAL CO (JP) | 2009-02-18 | — | — | CN | disclosed |
| US-7482357-B2 | 17-acetamido-4-azasteroid derivatives as androgen receptor modulators | MERCK & CO., INC. (US) | 2009-01-27 | — | — | US | disclosed |
| US-7482357-B2 | 17-acetamido-4-azasteroid derivatives as androgen receptor modulators | MERCK & CO., INC. (US) | 2009-01-27 | — | — | US | disclosed |
| EP-1961733-A1 | METHOD FOR SELECTIVELY PRODUCING PRIMARY AMINE COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2008-08-27 | — | — | EP | disclosed |
| US-20030158218-A1 | Thrombin inhibitors | NANTERMET PHILIPPE G (US) | 2003-08-21 | — | — | US | disclosed |
| JP-H09176121-A | PRODUCTION OF CHLORO-(AMINOMETHYL)PYRIDINES | KOEI CHEM CO LTD | 1997-07-08 | — | — | JP | disclosed |
| US-4794121-A | ANTISPASMODIC, BRONCHODILATOR, ANTICONVULSANT, ANALGESIC, HYPOTENSIVE, OR BRADYCARDIAL AGENT; ADRENERGIC STIMULANT | PANMEDICA (FR) | 1988-12-27 | — | — | US | disclosed |
| US-4112100-A | INCREASING THE ENDOGENOUS PRODUCTION OF PROSTAGLANDINS | THE UPJOHN COMPANY (US) | 1978-09-05 | — | — | US | disclosed |
| US-4069224-A | N-(PYRIDYLALKYL)BENZAMIDES, IMPROVE PRODUCTION OF PROSTAGLANDINS IN MAMMALS | THE UPJOHN COMPANY (US) | 1978-01-17 | — | — | US | disclosed |
| US-4008326-A | INCREASING PRODUCTION OF PROSTAGLANDINS | THE UPJOHN COMPANY (US) | 1977-02-15 | — | — | US | disclosed |